ATXN7L3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.181600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.456200E-01
Normal-vs-Stage2
5.022600E-01
Normal-vs-Stage3
9.857800E-01
Normal-vs-Stage4
8.856600E-01
Stage1-vs-Stage2
7.814600E-01
Stage1-vs-Stage3
8.291000E-01
Stage1-vs-Stage4
4.751600E-01
Stage2-vs-Stage3
7.600800E-01
Stage2-vs-Stage4
3.492600E-01
Stage3-vs-Stage4
9.700400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.961200E-01
Normal-vs-AfricanAmerican
8.467600E-01
Normal-vs-Asian
6.733000E-01
Caucasian-vs-AfricanAmerican
5.327000E-01
Caucasian-vs-Asian
9.681600E-01
AfricanAmerican-vs-Asian
7.164800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.245800E-01
Normal-vs-Female
6.481200E-01
Male-vs-Female
2.726000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.661400E-01
Normal-vs-Age(41-60Yrs)
8.937800E-01
Normal-vs-Age(61-80Yrs)
3.952600E-01
Normal-vs-Age(81-100Yrs)
4.142600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.607800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.350600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.838000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.102200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.375600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.569800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.995000E-01
Normal-vs-Daily Drinker
5.487000E-01
Normal-vs-Weekly Drinker
5.878000E-01
Normal-vs-Occasional Drinker
9.048200E-01
Normal-vs-Social Drinker
6.441000E-01
Non Drinker-vs-Daily Drinker
5.227800E-01
Non Drinker-vs-Weekly Drinker
4.793600E-01
Non Drinker-vs-Occasional Drinker
4.196300E-02
Non Drinker-vs-Social Drinker
1.741830E-01
Daily Drinker-vs-Weekly Drinker
8.797200E-01
Daily Drinker-vs-Occasional Drinker
2.122000E-01
Daily Drinker-vs-Social Drinker
5.613000E-01
Weekly Drinker-vs-Occasional Drinker
3.165200E-01
Weekly Drinker-vs-Social Drinker
6.829200E-01
Occasional Drinker-vs-Social Drinker
4.874200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.322100E-02
Normal-vs-Grade 2
4.479400E-01
Normal-vs-Grade 3
4.396800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.695200E-01
Grade 1-vs-Grade 3
2.627600E-01
Grade 1-vs-Grade 4
8.322100E-02
Grade 2-vs-Grade 3
7.454200E-01
Grade 2-vs-Grade 4
4.479400E-01
Grade 3-vs-Grade 4
4.396800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.842240E-01
Normal-vs-NonDiabetic
6.658400E-01
Diabetic-vs-NonDiabetic
9.103200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.222600E-01
Normal-vs-NoPancreatitis
4.572000E-01
Pancreatitis-vs-NoPancreatitis
1.041230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.972200E-01
Normal-vs-N1
5.169000E-01
N0-vs-N1
8.955800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.232600E-01
Normal-vs-TP53-NonMutant
3.330800E-01
TP53-Mutant-vs-TP53-NonMutant
4.758800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
